Menu
GeneBe

rs754729248

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 7P and 4B. PP3PP4PP1_StrongBS1PM5_Supporting

This summary comes from the ClinGen Evidence Repository: The c.1136C>A variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of proline to threonine at codon 379 (p.(Pro379Thr)) of NM_000545.6. This variant has a Popmax Filtering allele frequency in gnomAD 2.1.1 of 0.00003898, which is greater than the MDEP threshold for BS1 (greater than or equal to 0.000033) (BS1). This variant was identified in 13 unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4 cannot be applied because the variant MAF in gnomAD is above the ClinGen MDEP PM2_Supporting cutoff (PMIDs 21170474, 15657605, internal lab contributors). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.967, which is greater than the MDEP threshold of 0.70 (PP3). This variant was identified in an individual with a MODY probability calculator result >50% and negative genetic testing for HNF4A (PP4; internal lab contributor). This variant segregated with diabetes, with at least 4 informative meioses in 3 families (PP1_Strong; internal lab contributors). Another missense variant, c.1136C>G p.Pro379Arg, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Pro379Thr (PM5_Supporting). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 2.1.0, approved 8/11/2023): BS1, PP3, PP4, PP1_Strong, PM5_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA6831957/MONDO:0015967/017

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000018 ( 0 hom. )

Consequence

HNF1A
NM_000545.8 missense

Scores

11
4
2

Clinical Significance

Uncertain significance reviewed by expert panel P:4U:4

Conservation

PhyloP100: 7.89
Variant links:
Genes affected
HNF1A (HGNC:11621): (HNF1 homeobox A) The protein encoded by this gene is a transcription factor required for the expression of several liver-specific genes. The encoded protein functions as a homodimer and binds to the inverted palindrome 5'-GTTAATNATTAAC-3'. Defects in this gene are a cause of maturity onset diabetes of the young type 3 (MODY3) and also can result in the appearance of hepatic adenomas. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM5
PP1
PP3
PP4
BS1

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
HNF1ANM_000545.8 linkuse as main transcriptc.1135C>A p.Pro379Thr missense_variant 6/10 ENST00000257555.11
HNF1ANM_001306179.2 linkuse as main transcriptc.1135C>A p.Pro379Thr missense_variant 6/10
HNF1ANM_001406915.1 linkuse as main transcriptc.1135C>A p.Pro379Thr missense_variant 6/9
HNF1AXM_024449168.2 linkuse as main transcriptc.1135C>A p.Pro379Thr missense_variant 6/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
HNF1AENST00000257555.11 linkuse as main transcriptc.1135C>A p.Pro379Thr missense_variant 6/101 NM_000545.8 P4

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152172
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.0000240
AC:
6
AN:
250080
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135380
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000177
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000178
AC:
26
AN:
1461638
Hom.:
0
Cov.:
36
AF XY:
0.0000165
AC XY:
12
AN XY:
727136
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000246
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.0000188
Gnomad4 NFE exome
AF:
0.0000108
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152172
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000251
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Pathogenic:4Uncertain:4
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Pathogenic:2Uncertain:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 22, 2023This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 379 of the HNF1A protein (p.Pro379Thr). This variant is present in population databases (rs754729248, gnomAD 0.01%). This missense change has been observed in individuals with maturity-onset diabetes of the young (PMID: 18003757, 21683639, 22808921, 23348805, 23803251, 25935773, 26479152, 28012402, 28170077, 30293189). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 972818). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt HNF1A protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 18, 2023In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 32910913, 18003757, 21224407, 28170077, 23348805, 36208343, 34108472, 28012402, 21683639, 16917892, 26479152, 15883474, 15657605, 36208030, 30293189) -
Likely pathogenic, criteria provided, single submitterclinical testingAthena DiagnosticsMar 22, 2023The frequency of this variant in the general population is consistent with pathogenicity (http://gnomad.broadinstitute.org). This variant has been identified in at least one individual with clinical features associated with this gene and appears to segregate with disease in multiple families (personal communication from ClinGen Monogenic Diabetes Expert Panel). At least one other missense variant at this codon is considered to be pathogenic or likely pathogenic, suggesting this variant may also cause disease. Computational tools predict that this variant is damaging. -
Maturity-onset diabetes of the young type 3 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testing3billionMar 22, 2022Different pathogenic/likely pathogenic amino acid change has been reported with supporting evidence at the same codon (PMID:18003757,18003757,15883474,15657605). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.967>=0.6). A missense variant is a common mechanism . Therefore, this variant is classified as uncertain significance according to the recommendation of ACMG/AMP guideline. -
Pathogenic, criteria provided, single submittercurationBroad Center for Mendelian Genomics, Broad Institute of MIT and HarvardJan 22, 2020The p.Pro379Thr variant in HNF1A has been reported in 10 individuals with maturity-onset diabetes of the young, segregated with disease in 9 affected relatives from 3 families (PMID: 30293189, 21683639, 26479152, 28012402), and has been identified in 0.011% (4/35382) of Latino chromosomes and 0.002% (3/128426) European (non-Finnish) chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs754729248). Please note that for diseases with clinical variability, or reduced penetrance, pathogenic variants may be present at a low frequency in the general population. The number of reported affected individuals with this variant is slightly greater than expected compared to non-affected individuals with this variant. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. Multiple variants in the same region as p.Pro379Thr have been reported in association with disease in the literature (PMID: 23348805, 16917892). Two additional likely pathogenic variants, resulting in a different amino acid change at the same position, p.Pro379Arg and p.Pro379His, have been reported in association with disease in the literature, supporting that a change at this position may not be tolerated (PMID: 23348805, 16917892, 29666556, 15657605, 23348805, 16917892, 15883474). In summary, this variant meets criteria to be classified as pathogenic for maturity-onset diabetes of the young in an autosomal dominant manner based on segregation with disease, location in a mutation hotspot, and two likely pathogenic variants that affect the same amino acid. ACMG/AMP Criteria applied: PP1_Strong, PM1, PM5, PP3, PS4_Supporting (Richards 2015). -
Maturity onset diabetes mellitus in young Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineNov 06, 2020The p.Pro379Thr variant in HNF1A has been reported in at least 10 individuals with maturity-onset diabetes of the young (MODY) and segregated with disease in at least 6 affected relatives from 3 families (Wang 2019 PMID: 30293189, Kyithar 2011 21683639, Bacon 2016 26479152, Giuffrida 2017 28012402, Santana 2017 PMID: 28170077, Bellanné-Chantelot 2008 PMID: 18003757). It has been identified in 0.011% (4/35382) of Latino chromosomes and 0.002% (3/128426) European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The p.Pro379 codon is one of the most frequently mutated sites in the HNF1A gene (Ellard and Colclough 2013 PMID: 23348805). In summary, although additional studies are required to fully establish its clinical significance, this variant meets criteria to be classified as likely pathogenic for autosomal dominant MODY. ACMG/AMP Criteria applied: PP1_Moderate, PM1, PP3, PS4_Moderate. -
Monogenic diabetes Uncertain:1
Uncertain significance, reviewed by expert panelcurationClinGen Monogenic Diabetes Variant Curation Expert PanelAug 14, 2023The c.1136C>A variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of proline to threonine at codon 379 (p.(Pro379Thr)) of NM_000545.6. This variant has a Popmax Filtering allele frequency in gnomAD 2.1.1 of 0.00003898, which is greater than the MDEP threshold for BS1 (greater than or equal to 0.000033) (BS1). This variant was identified in 13 unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4 cannot be applied because the variant MAF in gnomAD is above the ClinGen MDEP PM2_Supporting cutoff (PMIDs 21170474, 15657605, internal lab contributors). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.967, which is greater than the MDEP threshold of 0.70 (PP3). This variant was identified in an individual with a MODY probability calculator result >50% and negative genetic testing for HNF4A (PP4; internal lab contributor). This variant segregated with diabetes, with at least 4 informative meioses in 3 families (PP1_Strong; internal lab contributors). Another missense variant, c.1136C>G p.Pro379Arg, has been classified as pathogenic by the ClinGen MDEP but has a greater Grantham distance than p.Pro379Thr (PM5_Supporting). In summary, this variant meets the criteria to be classified as a variant of uncertain significance for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP (specification version 2.1.0, approved 8/11/2023): BS1, PP3, PP4, PP1_Strong, PM5_Supporting. -
Type 1 diabetes mellitus 20 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJan 07, 2020This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.79
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.53
CADD
Pathogenic
28
DANN
Uncertain
1.0
Eigen
Pathogenic
0.71
Eigen_PC
Uncertain
0.63
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.94
D;D;D;D
M_CAP
Pathogenic
0.86
D
MetaRNN
Pathogenic
0.99
D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationTaster
Benign
1.0
D;D;D;D;D
PrimateAI
Pathogenic
0.83
D
PROVEAN
Uncertain
-4.0
D;.;D;D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D;.;D;D
Sift4G
Benign
0.072
T;T;T;T
Polyphen
1.0
.;.;.;D
Vest4
0.95
MutPred
0.93
Loss of catalytic residue at P378 (P = 0.0116);Loss of catalytic residue at P378 (P = 0.0116);Loss of catalytic residue at P378 (P = 0.0116);Loss of catalytic residue at P378 (P = 0.0116);
MVP
0.98
MPC
0.59
ClinPred
0.94
D
GERP RS
4.6
gMVP
0.81

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs754729248; hg19: chr12-121434371; API